Outcome After Radical Cystectomy With Limited or Extended Pelvic Lymph Node Dissection
Abstract
Purpose:
We compared recurrence patterns and survival of patients with urothelial bladder cancer undergoing radical cystectomy who either had limited or extended pelvic lymph node dissection at 2 institutions between 1987 and 2000.
Materials and Methods:
Two consecutive series of patients treated with radical cystectomy and limited pelvic lymph node dissection (336; Cleveland Clinic) and extended pelvic lymph node dissection (322; University of Bern) were analyzed. All cases were staged N0M0 prior to radical cystectomy, and none were treated with neoadjuvant radiotherapy or chemotherapy. Patients with PTis/pT1 and pT4 disease were excluded from analysis. Pathological characteristics based on the 1997 TNM system and recurrence patterns were determined.
Results:
The overall lymph node positive rate was 13% for patients with limited and 26% for those who had extended pelvic lymph node dissection. The 5-year recurrence-free survival of patients with lymph node positive disease was 7% for limited and 35% for extended pelvic lymph node dissection. The 5-year recurrence-free survival for pT2pN0 cases was 67% for limited and 77% for extended pelvic lymph node dissection, and the respective percentages for pT3pN0 cases were 23% and 57% (p <0.0001). The 5-year recurrence-free survival for pT2pN0-2 cases was 63% for limited and 71% for extended pelvic lymph node dissection, and for pT3pN0-2 cases the respective figures were 19% and 49% (p <0.0001). Incidence of local and systemic failure correlated closely with pathological stage for both series.
Conclusions:
Our data suggest that limited pelvic lymph node dissection is associated with suboptimal staging, poorer outcome for patients with node positive and node negative disease, and a higher rate of local progression. Extended pelvic lymph node dissection allows for more accurate staging and improved survival of patients with nonorgan confined and lymph node positive disease.
References
- 1 : Management of invasive bladder cancer: a meticulous pelvic node dissection can make a difference. J Urol1982; 128: 34. Link, Google Scholar
- 2 : Radical cystectomy for carcinoma of the bladder: critical evaluation of the results in 1,026 cases. J Urol1997; 158: 393. Link, Google Scholar
- 3 : Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol2001; 19: 666. Crossref, Medline, Google Scholar
- 4 : Radical cystectomy for bladder cancer today–a homogeneous series without neoadjuvant therapy. J Clin Oncol2003; 21: 690. Google Scholar
- 5 :
Lymphadenectomy technique . In: . Baltimore: Williams & Wilkins1989. Google Scholar - 6 : Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy. J Urol2001; 166: 19. Link, Google Scholar
- 7 : Radical cystectomy without radiation therapy for carcinoma of the bladder. J Urol1984; 131: 477. Link, Google Scholar
- 8 : Limitations of computerized tomography in staging invasive bladder cancer before radical cystectomy. J Urol2000; 163: 1693. Link, Google Scholar
- 9 : Magnetic resonance imaging in the staging of bladder cancer. Br J Urol1993; 71: 566. Google Scholar
- 10 : Positron emission tomography for prostate, bladder, and renal cancer. Semin Nucl Med2004; 34: 274. Google Scholar
- 11 : Stage specific lymph node metastasis mapping in radical cystectomy specimens. J Urol2004; 171: 1830. Link, Google Scholar
- 12 : Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. J Urol2004; 171: 139. Link, Google Scholar
- 13 : Lymph node involvement in patients with bladder cancer treated with radical cystectomy: a patho-anatomical study–a single center experience. J Urol2004; 172: 1818. Link, Google Scholar
- 14 : Pelvic lymph node dissection can be curative in patients with node positive bladder cancer. J Urol1999; 161: 449. Link, Google Scholar
- 15 : Outcomes in patients with urothelial carcinoma of the bladder with limited pelvic lymph node dissection. BJU Int2006; 98: 1172. Google Scholar
- 16 : Presentation, methods of diagnosis and therapy for pelvic recurrence following radical cystectomy for transitional cell carcinoma of the bladder. J Urol1998; 159: 792. Link, Google Scholar
- 17 : Extent of surgery and pathology evaluation has an impact on bladder cancer outcomes after radical cystectomy. Urology2003; 61: 105. Google Scholar
- 18 : Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. BJU Int2000; 85: 817. Crossref, Medline, Google Scholar
- 19 : Detection of occult tumor cells in lymph nodes from bladder cancer patients by MUC7 nested RT-PCR. Eur Urol2004; 45: 314. Google Scholar
- 20 : The Will Rogers phenomenon: Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med1985; 312: 1604. Google Scholar
